BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shih CA, Chen WC. Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy. World J Clin Cases 2021; 9(21): 5769-5781 [PMID: 34368296 DOI: 10.12998/wjcc.v9.i21.5769]
URL: https://www.wjgnet.com/1948-5182/full/v9/i21/5769.htm
Number Citing Articles
Jia-Rui Zheng, Zi-Long Wang, Bo Feng. Hepatitis B functional cure and immune responseFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1075916
Sara Lacerda Pereira, Raquel Duro, António Sarmento. Late Hepatitis B reactivation after treatment with rituximabIDCases 2022; 27: e01393 doi: 10.1016/j.idcr.2022.e01393
Caterina Sagnelli, Antonello Sica, Massimiliano Creta, Alessandra Borsetti, Massimo Ciccozzi, Evangelista Sagnelli. Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19Pathogens 2022; 11(5): 567 doi: 10.3390/pathogens11050567
Chunyan Yuan, Jing Peng, Renxiang Xia, Jian He, Tianji Qiu, Yunqing Yao. Reactivation of Occult Hepatitis B Virus Infection During Long-Term Entecavir Antiviral TherapyFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.865124